Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jolly Pharmaceutical Co. Ltd.

Zhejiang Jolly Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
80,997.50
106,757.30
93,636.40
81,973.00
53,176.50
26,186.40
Depreciation, Depletion & Amortization
20,686.30
25,363.60
31,945.30
38,892.70
41,350.00
45,429.80
Other Funds
17,183.70
7,964.10
415,166.80
38,665.20
36,700.80
18,992
Funds from Operations
107,902.00
140,302.80
138,171.60
143,207.70
122,983.70
91,243
Changes in Working Capital
78,398.20
126,607.60
40,503.00
74,543.50
112,773.80
11,707.50
Net Operating Cash Flow
29,503.80
13,695.20
97,668.70
68,664.20
10,209.80
79,535.50
Capital Expenditures
23,730.60
39,299.00
26,084.10
143,240.70
124,397.90
Sale of Fixed Assets & Businesses
700.00
1,493.90
74.80
12,751.30
9,588.90
Purchase/Sale of Investments
-
-
239,126.00
91,854.00
26,970.00
Net Investing Cash Flow
21,780.60
111,497.00
331,361.80
234,556.10
150,602.40
Cash Dividends Paid - Total
-
72,000.00
63,360.00
42,603.70
12,172.50
Issuance/Reduction of Debt, Net
1,620.00
49,710.00
86,300.00
121,070.00
33,500.00
Net Financing Cash Flow
15,563.70
14,325.90
438,106.80
39,801.00
15,373.30
Net Change in Cash
7,848.60
112,125.40
204,415.90
126,089.50
155,768.20
Free Cash Flow
5,773.20
25,603.80
71,584.60
74,576.40
114,188.10
Deferred Taxes & Investment Tax Credit
25.80
172.20
39.40
1,122.00
1,894.40
634.70
Net Assets from Acquisitions
-
84,112.00
66,226.60
12,212.80
8,823.50
Other Sources
1,250.00
10,420.00
-
-
-
Exchange Rate Effect
8.20
2.30
2.30
1.40
2.30

About Zhejiang Jolly Pharmaceutical Co.

View Profile
Address
No. 388 Zhiyuan North Road
Huzhou Zhejiang 313200
China
Employees -
Website -
Updated 07/08/2019
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research & development, production and distribution of pharmaceuticals as well as Chinese herbal medicines. Its products include wuling powder, wuling capsule, linglianhua particle, clindamycin phosphate injection, doxapram injection, pefloxacin mesylate injection, azithromycin injection and sodium nitroprusside injection. The company was founded on January 28, 2000 and is headquartered Huzhou, China.